Neal C Bradsher insider trades

Open-market stock purchases and sales by Neal C Bradsher, Director, 10% Owner at Lineage Cell Therapeutics, Inc, from SEC Form 4 filings since Jul 1, 2025.

Recent trades

DateStockTradeValue
Jul 1, 2026LCTX Lineage Cell Therapeutics, IncBought (not open market)—
Jun 18, 2026STAA Staar Surgical CoBought (not open market)—
Mar 6, 2026STAA Staar Surgical CoBought (not open market)—

Companies traded

  • LCTX Lineage Cell Therapeutics, Inc: other filings, last Jul 1, 2026
  • STAA Staar Surgical Co: other filings, last Jun 18, 2026

Get free alerts when Neal C Bradsher files a new trade →